Up Next
Back to Show
Amanpour & Co.
Jennifer Doudna on FDA Approval of First CRISPR Treatments
More than a decade ago, pioneering biochemist Jennifer Doudna co-invented CRISPR, the gene editing technology which earned her the Nobel Prize in chemistry. Now, the very first treatment based on CRISPR has been approved in the U.K. and the U.S., a landmark decision for the treatment of sickle cell disease and for the potential of this rapidly advancing field. Dr. Doudna joins to discuss.
Sign up now for inspiring and thought-provoking media delivered straight to your inbox.
Support Provided By
Unlock with PBS Passport
55:47
John Kerry; Laura Bates; David Liu
Unlock with PBS Passport
55:34
Aviva Siegel; Sir Geoffrey Nice; Joni Levin & Keith Clarke; Hari w/John Vaillant
Unlock with PBS Passport
55:37
Alex Marquardt; Ronald Lamola; Tom Fletcher; Kate Kelly
Unlock with PBS Passport
55:46
Bridget Brink; Wilfred Frost; Mitch Daniels
Unlock with PBS Passport
55:46
Jeremy Diamond; Rim Turkmani; Bonny Lin; Ian Bremmer
Unlock with PBS Passport
55:36
Ivo Daalder; Ronen Bergman; Vladimir Bortun; Ron Chernow
Unlock with PBS Passport
55:47
Akinwumi Adesina; Daniel Kehlmann; Karen Attiah
Unlock with PBS Passport
55:38
Dmytro Kuleba; Wendy Sherman; Dr. Jerry Avorn
Unlock with PBS Passport
55:47
Jeff Zeleny; Matteo Renzi; Alon-Lee Green and Rula Daood; Thomas Friedman
Unlock with PBS Passport
55:46
Daniel Kurtzer; Jordan Thomas; Kelsey Grammer
Unlock with PBS Passport
55:47
Ronen Neutra and Orna Neutra; Emily Feng and Felix Salmon; Cardinal Michael Czerny; Randi Weingarten
Unlock with PBS Passport
55:31
Alexander Stubb; Christo Grozev; James Jones; David Yaffe-Bellany